Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Phase 1 Study of Rezatapopt, a p53 Reactivator, in
TP53
Y220C–Mutated Tumors
Aparna R. Parikh
Links
DOI
PubMed
Journal
New England Journal of Medicine
Institutions
Massachusetts General Hospital
Authors
Aparna R. Parikh
Funding
This study was sponsored by PMV Pharmaceuticals, Inc. Funding